
Quarter End | |||
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | |||
Operating Income | |||
Pre Tax Income | |||
Net Income | |||
Preferred Dividends | |||
Basic Earnings Per Share (EPS) | |||
EBIT | |||
EBITDA |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -1.94M | -571k | -1.71M |
Pre Tax Income | -2.15M | -1.05M | -1.81M |
Net Income | -2.15M | -1.05M | -1.81M |
Preferred Dividends | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.266 | -0.102 | -0.172 |
EBIT | -1.94M | -571k | -1.71M |
EBITDA | -1.85M | -411k | -1.55M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.